Business Context and Reporting Period
Company: CorMedix Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2018
Reporting Period: Second quarter and six months ended June 30, 2018.
Context: This filing serves to announce the company's operating results for the specified period via a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide clear values for these metrics.
Material Changes
No specific material changes or comparative financial data are detailed in the provided text. The document solely indicates that results for the second quarter and six months ended June 30, 2018, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release by reference but does not include the text of the commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are listed in the provided text.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings except as expressly set forth.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for actual financial figures, as they are not present in the 8-K cover sheet.
- Verify the specific operating results for the quarter and six months ended June 30, 2018, in the referenced exhibit.
- Confirm the status of the company's cash position and liquidity from the detailed financial statements referenced in the press release.
- Note that the financial data in the press release is not considered "filed" under Section 18 of the Exchange Act.